Gustave Roussy International – Egypt shared on LinkedIn:
“Advancing multidisciplinary excellence in oncology care.
Gustave Roussy International – Egypt, in collaboration with the Presidential Initiative for Early Detection and Treatment of Cancer and EVA Pharma, recently hosted a specialized Lung Cancer Multidisciplinary Team (MDT) Preceptorship.
Designed to empower healthcare professionals with advanced clinical knowledge and practical skills, the program focused on the power of collaborative decision-making, treatment planning, and personalized patient management.
This initiative is part of our broader ongoing commitment to supporting national efforts in lung cancer awareness—educating the community on risk factors and early warning signs, while promoting timely diagnosis and access to appropriate screening and treatment pathways.”
You can also read: International Lung Cancer Summit 2026: From Molecular Targets to the Next Era of Precision Thoracic Oncology
